NeoGenomics (NEO) COO exercises RSUs, shares withheld for tax
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NeoGenomics, Inc. President & Chief Operating Officer Warren Stone reported routine equity compensation activity involving restricted stock units and stock options. On May 2, 2026, he exercised awards to acquire 5,969 shares of common stock, with 2,349 shares withheld by the company to cover tax obligations related to the RSU release.
Following these transactions, Stone holds 161,985 shares of common stock directly, along with a substantial remaining equity incentive position, including 253,378 stock options at an exercise price of $10.81 and 166,113 stock options at $11.21, plus significant restricted and performance stock units that vest over future years.
Positive
- None.
Negative
- None.
Insider Trade Summary
5,969 shares exercised/converted
Mixed
19 txns
Insider
Stone Warren
Role
Pres & Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 5,969 | $0.00 | -- |
| Exercise | Common Stock | 5,969 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,349 | $0.00 | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 11,939 shares (Direct, null);
Common Stock — 164,334 shares (Direct, null);
Stock Option (Right to Buy) — 166,113 shares (Direct, null);
Performance Stock Unit — 21,204 shares (Direct, null)
Footnotes (1)
- Reflects the release of restricted stock units that were previously reported on a Form 4. Each restricted stock unit is the economic equivalent of one share of NeoGenomics, Inc. common stock and is converted into common stock upon vesting. Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. On May 2, 2024, Mr. Stone was granted 17,905 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. Once vested, the shares of common stock are not subject to expiration. On December 1, 2022, Mr. Stone was granted 166,113 stock options. The options vest ratably over the first four anniversary dates of the grant date. On May 11, 2023, Mr. Stone was granted 53,969 stock options. The options vest ratably over the first three anniversary dates of the grant date. On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. On February 23, 2024, Mr. Stone was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date. On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company. On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. On May 2, 2024, Mr. Stone was granted 29,976 stock options. The options vest ratably over the first three anniversary dates of the grant date. On May 2, 2024, Mr. Stone was granted 17,908 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 26,862. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110% On February 21, 2025, Mr. Stone was granted 143,266 stock options. At the time of the grant, the options vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these options was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date. On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grantdate. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%. On April 1, 2025, Mr. Stone was granted 94,518 stock options. The options vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date. On April 1, 2025, Mr. Stone was granted 52,687 restricted stock units. The restricted stock units vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 multiplied by 110%. On March 1, 2026, Mr. Stone was granted 253,378 stock options. The options vest ratably over the first three anniversary dates of the grant date. On March 1, 2026, Mr. Stone was granted 152,594 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Key Figures
RSU-derived shares exercised: 5,969 shares
Shares withheld for taxes: 2,349 shares
Direct common stock holdings: 161,985 shares
+5 more
8 metrics
RSU-derived shares exercised
5,969 shares
Common stock acquired via RSU exercise on May 2, 2026
Shares withheld for taxes
2,349 shares
Common stock withheld to satisfy tax obligations on RSU release
Direct common stock holdings
161,985 shares
Common stock held directly after reported transactions
Stock options at $10.81
253,378 underlying shares
Options with $10.81 exercise price expiring March 1, 2036
Stock options at $11.21
166,113 underlying shares
Options with $11.21 exercise price expiring December 1, 2029
Premium-price stock options at $19.65
53,969 underlying shares
Options with $19.65 exercise price expiring May 11, 2030
Restricted stock units
152,594 units
RSUs granted March 1, 2026, vesting over three years
Performance stock units grant
25,330 units
PSUs granted February 23, 2024, with up to 37,996 shares at maximum
Key Terms
Restricted Stock Unit, Performance Stock Unit, premium-price stock option, tax withholding obligations, +2 more
6 terms
Restricted Stock Unit financial
"Reflects the release of restricted stock units that were previously reported on a Form 4."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Performance Stock Unit financial
"was granted 21,204 performance stock units representing the number of shares that may vest at target performance."
A performance stock unit is a type of reward companies give to employees, usually managers, that depends on how well the company performs over time. If the company hits specific goals, the employee earns shares of stock, like earning a prize for reaching certain levels in a game. It motivates employees to work hard because their rewards are tied to the company's success.
tax withholding obligations financial
"withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock"
exercise or conversion of derivative security financial
"Exercise or conversion of derivative security"
cumulative fiscal year revenue goal financial
"based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts"
FAQ
What did NeoGenomics (NEO) executive Warren Stone report in this Form 4?
Warren Stone reported routine equity compensation activity. He exercised restricted stock units into 5,969 common shares, while 2,349 shares were withheld to satisfy tax obligations. The filing also details his remaining stock option, restricted stock unit, and performance stock unit holdings.
How many restricted stock units and performance stock units does Warren Stone have at NeoGenomics?
The filing shows substantial outstanding awards. These include 152,594 restricted stock units and multiple other RSU and performance stock unit grants, such as 59,382 and 9,613 RSUs, and 21,204 and 25,330 performance stock units, each subject to vesting schedules and performance or service conditions.
What stock options does Warren Stone hold according to the NeoGenomics Form 4?
Stone holds several significant option grants, including 253,378 stock options at a $10.81 exercise price, 166,113 options at $11.21, 53,969 options at $19.65, and 94,518 options at $10.44 or $16.45. These options generally vest over multi-year schedules and have expirations extending into the 2030s.
What are the key terms of Warren Stone’s performance stock units at NeoGenomics?
Performance stock units granted to Stone, such as 21,204 and 25,330 units, vest based on share price growth and revenue growth goals. Footnotes state that maximum vesting can reach 31,806 and 37,996 shares respectively if specified performance criteria and continued service requirements are fully achieved.